{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T05:42:08Z","timestamp":1672465328025},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11912-021-01082-2","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T15:03:11Z","timestamp":1623682991000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of Intractable Symptoms in Oncologic Care"],"prefix":"10.1007","volume":"23","author":[{"given":"Katie L.","family":"Dziedzic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross H.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"1082_CR1","unstructured":"Pharo GH. Pharmacologic Management of Cancer Pain. JAOA Supplement 5. 2005;105(11):S21\u2013S28."},{"key":"1082_CR2","unstructured":"Wickham, RJ. Nausea and vomiting not related to cancer therapy: intractable problem or clinical challenge? J Adv Pract Oncol. 2020;11(5):476\u2013488."},{"key":"1082_CR3","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1200\/JCO.20.01296","volume":"38","author":"PJ Heskuth","year":"2020","unstructured":"Heskuth PJ. Antiemetics: ASCO Guideline Update. J Clin Oncol. 2020;38:2782\u201397.","journal-title":"J Clin Oncol"},{"key":"1082_CR4","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.2147\/OTT.S158570","volume":"11","author":"RM Navari","year":"2018","unstructured":"Navari RM. Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting. OncoTargets Ther. 2018;11:6459\u201378.","journal-title":"OncoTargets Ther"},{"key":"1082_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1515725","volume":"375","author":"RM Navari","year":"2016","unstructured":"\u2022 Navari RM. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;375:134\u201342 This study demonstrated significant benefit of adding olanzapine, a relatively inexpensive medication, to treat or prevent CINV. Results showed benefit in reducing vomiting as well as nausea itself. Most side effects were shown to be transient.","journal-title":"N Engl J Med"},{"key":"1082_CR6","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00520-018-4593-3","volume":"27","author":"SG Harder","year":"2019","unstructured":"Harder SG. Antiemetic use of olanzapine in patients with advanced cancer: results from an open label multicenter study. Support Care Cancer. 2019;27:2849\u201356.","journal-title":"Support Care Cancer"},{"key":"1082_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1164\/rccm.201108-1463ED","volume":"184","author":"C Peiffer","year":"2011","unstructured":"Peiffer C. Morphine-induced relief of dyspnea: what are the mechanisms. Am J Respir Crit Care Med. 2011;184:867\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1082_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ygyno.2015.02.026","volume":"137","author":"LM Landrum","year":"2015","unstructured":"Landrum LM. Comprehensive care in gynecologic oncology: the importance of palliative care. Gynecol Oncol. 2015;137:193\u2013202.","journal-title":"Gynecol Oncol"},{"key":"1082_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jpainsymman.2015.10.022","volume":"51","author":"WL Chan","year":"2016","unstructured":"Chan WL. Effective management of breathlessness in advanced cancer patients with a program-based, multidisciplinary approach: the \"SOB Program\" in Hong Kong. J Pain Symptom Manag. 2016;51:623\u20137.","journal-title":"J Pain Symptom Manag"},{"key":"1082_CR10","first-page":"590","volume":"583-85","author":"MS Patel","year":"2018","unstructured":"Patel MS. Strategies for the optimal management of dyspnea in cancer patients with advanced illnesS. Oncology. 2018;583-85:590.","journal-title":"Oncology"},{"issue":"7","key":"1082_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1513\/AnnalsATS.201504-249ED","volume":"12","author":"RA Mularski","year":"2015","unstructured":"Mularski RA. Managing dyspnea in advanced chronic obstructive pulmonary disease: balancing all the evidence. Ann Am Thorac Soc. 2015;12(7):978\u201380.","journal-title":"Ann Am Thorac Soc"},{"key":"1082_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1378\/chest.14-0800","volume":"147","author":"DA Mahler","year":"2015","unstructured":"Mahler DA. Recent advanced in dyspnea. Chest. 2015;147:232\u201341.","journal-title":"Chest"},{"key":"1082_CR13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1164\/rccm.200605-587ST","volume":"177","author":"PN Lanken","year":"2008","unstructured":"Lanken PN. An official American thoracic society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177:912\u201327.","journal-title":"Am J Respir Crit Care Med"},{"key":"1082_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1089\/jpm.2011.0110","volume":"15","author":"AH Kamal","year":"2012","unstructured":"Kamal AH. Dyspnea review for the palliative care professional: treatment goals and therapeutic options. J Palliat Med. 2012;15:106\u201314.","journal-title":"J Palliat Med"},{"key":"1082_CR15","doi-asserted-by":"crossref","unstructured":"Johnson MB. Gaps in the evidence base of opioids of refractory breathlessness. A future work plan? J Pain Symptom Manag. 2012;43(3):614\u201324.","DOI":"10.1016\/j.jpainsymman.2011.04.024"},{"key":"1082_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/SPC.0b013e32832b725e","volume":"3","author":"GT Buckholz","year":"2009","unstructured":"Buckholz GT. Nonpharmacologic management of dyspnea. Curr Opin Support Palliat Care. 2009;3:98\u2013102.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1082_CR17","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MHJ Van den Beuken-van Everdingen","year":"2007","unstructured":"Van den Beuken-van Everdingen MHJ. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437\u201349.","journal-title":"Ann Oncol"},{"key":"1082_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","volume":"57","author":"ML McPherson","year":"2019","unstructured":"McPherson ML. Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manag. 2019;57:635\u2013645.e4.","journal-title":"J Pain Symptom Manag"},{"key":"1082_CR19","doi-asserted-by":"crossref","unstructured":"\u2022 Cheung KWA. The use of ketamine in the management of refractory cancer pain in a palliative care unit. Ann Palliat Med. 2020;9(6):4478\u20134489. Ketamine infusions appear to show significant promise in reducing intractable pain and subsequently reducing patients\u2019 overall medication needs. These intermittent infusion therapies may be incorporated into patients\u2019 treatment plans through brief hospitalizations on oncology or palliative care units.","DOI":"10.21037\/apm.2019.09.09"},{"issue":"8","key":"1082_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/papr.12707","volume":"18","author":"L Ferrer-Mileo","year":"2018","unstructured":"Ferrer-Mileo L. Efficacy of cryoablation to control cancer pain: a systematic review. Pain Practice. 2018;18(8):1083\u201398.","journal-title":"Pain Practice"},{"issue":"19","key":"1082_CR21","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","volume":"20","author":"TJ Smith","year":"2002","unstructured":"Smith TJ. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20(19):4040\u20139.","journal-title":"J Clin Oncol"},{"key":"1082_CR22","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/pm\/pnw060","volume":"17","author":"BM Bruel","year":"2016","unstructured":"Bruel BM. Intrathecal therapy for cancer-related pain. Pain Med. 2016;17:2404\u201321.","journal-title":"Pain Med"},{"issue":"4","key":"1082_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1177\/0269216317751893","volume":"32","author":"RD Nipp","year":"2018","unstructured":"Nipp RD. Differential effects of early palliative care based on the age and sex of patients with advanced cancer from a randomized controlled trial. Palliat Med. 2018;32(4):757\u201366.","journal-title":"Palliat Med"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-021-01082-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-021-01082-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-021-01082-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T02:33:04Z","timestamp":1672453984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-021-01082-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1082"],"URL":"https:\/\/doi.org\/10.1007\/s11912-021-01082-2","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"30 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors has any potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"93"}}